A Prescription for Innovation

Overview

In a deal hailed as a potential disruptor to the U.S. pharmacy industry, Goodwin lawyers led PillPack, an innovative, full-service pharmacy, in its sale to Amazon.

Challenge

Prior to its sale to Amazon, PillPack had raised $118 million in financing from investors, including Accel, Accomplice, CRV and Founder Collective. The company turned to Goodwin to execute the transaction with Amazon.

Approach

A pharmacy designed to provide the best possible experience for customers, PillPack holds pharmacy licenses in all 50 states. For people who take multiple daily prescriptions, the company offers pre-sorted dose packaging, home delivery, and a commitment to customer service. These features help customers take medications as prescribed, which has been shown to improve health outcomes and lower costs.

To tackle this momentous deal, Goodwin assembled a cross-office, cross-practice team with members that included members of the technology companies, executive compensation, tax, antitrust,  employment, and IPTS practices.

Outcome

“PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology,” Jeff Wilke, Amazon CEO Worldwide Consumer, said in a statement. “PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier. We’re excited to see what we can do together on behalf of customers over time.”